GSK Acquires RAPT Therapeutics in $2.2B Deal

British pharmaceutical giant GSK Plc announces a definitive agreement to acquire US-based RAPT Therapeutics for $2.2 billion, expanding its pipeline in inflammatory and immunologic diseases.

Why Teens Prefer Texting: 5 Reasons

Teenagers today favor texting over phone calls and in-person chats. Discover five psychological and social reasons behind this digital communication shift.

Page 37 of 363